Cannell & Spears’s HCA Healthcare HCA Stock Holding History

Cannell & Spears’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$19.1M	Sell	40,292 -2,446	-6%	-$1.23M	0.37%	73
2025 Q4	$20M	Sell	42,738 -1,340	-3%	-$622K	0.37%	73
2025 Q3	$18.8M	Sell	44,078 -408	-0.9%	-$158K	0.35%	81
2025 Q2	$17M	Sell	44,486 -631	-1%	-$227K	0.34%	81
2025 Q1	$15.6M	Sell	45,117 -1,296	-3%	-$417K	0.34%	82
2024 Q4	$13.9M	Sell	46,413 -980	-2%	-$342K	0.29%	83
2024 Q3	$19.3M	Sell	47,393 -288	-0.6%	-$105K	0.38%	76
2024 Q2	$15.3M	Sell	47,681 -1,681	-3%	-$546K	0.32%	76
2024 Q1	$16.5M	Buy	+49,362	New	+$15.1M	0.34%	79

Other funds holding HCA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Cannell & Spears's HCA Position: Q1 2026 in Review

Cannell & Spears reduced its HCA Healthcare (HCA) stake by 5.7% in Q1 2026, selling an estimated $1.23M and leaving 40,292 shares worth $19.1M. The position accounts for 0.37% of the portfolio, ranked #73.

Cannell & Spears first reported a position in HCA in Q1 2024 and has held it in 9 quarters since. The position peaked at $20M in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

Cannell & Spears held 40,292 shares of HCA Healthcare worth $19.1M as of Q1 2026.
Cannell & Spears sold 2,446 HCA Healthcare shares in Q1 2026, an estimated $1.23M.
HCA Healthcare made up 0.37% of Cannell & Spears's portfolio in Q1 2026, its #73 holding.
Cannell & Spears first reported a position in HCA Healthcare in Q1 2024 and has held it in 9 quarters since.
Cannell & Spears's HCA Healthcare position peaked at $20M in Q4 2025.
1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Cannell & Spears's 13F filing for Q1 2026, filed 14 May 2026.